Neuphoria Therapeutics Inc Strategic Asset Allocation Index
Neuphoria Therapeutics Inc strategic asset allocation index. Neuphoria Therapeutics Inc (NEUP) has a Strategic Asset Allocation Index of 0.3% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $81.07K) total $81.07K, measured against net assets of $29.04 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See NEUP equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Neuphoria Therapeutics Inc (2021–2021)
Strategic asset allocation index of Neuphoria Therapeutics Inc from 2021 to 2021. This chart shows how Neuphoria Therapeutics Inc's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of December 2023, the index stands at 0.3%, representing strategic assets of $81.07K against net assets of $29.04 Million USD. Check how tangible is Neuphoria Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Neuphoria Therapeutics Inc Strategic Asset Allocation Index by Year (2021–2021)
Neuphoria Therapeutics Inc strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Neuphoria Therapeutics Inc from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Neuphoria Therapeutics Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.3% | $119.00K | $- | $119.00K | $35.76 Million | — |